RTX CEO Reiterates $289B Backlog, But Valuation Already Priced In

What happened

RTX Chairman and CEO Chris Calio publicly reiterated the company's $289 billion backlog, up 22% year over year, framing it as evidence of durable demand across commercial aerospace and defense. This figure is identical to the backlog stated in the company's Q2 2026 10-Q, so the announcement provides no new quantitative information to the market. At a market price of $217.90, RTX trades at 37.9x earnings and 21.7x EV/EBITDA, multiples that already discount strong aftermarket growth and defense restocking. The DeepValue master report maintains a WAIT rating, noting that while demand is robust, conversion into free cash flow remains the key risk amid persistent supply-chain and tariff pressures. Management's public emphasis on backlog size does not address the operational bottlenecks that could slow revenue recognition, leaving the investment thesis unchanged.

Implication

The CEO's public confirmation of the $289B backlog adds no incremental insight beyond what was already disclosed in the Q2 2026 filing. RTX's premium valuation leaves little room for execution missteps, and the stock is only attractive near the $195 entry level identified in the DeepValue report. The primary catalysts over the next 3-6 months remain free cash flow delivery within the $8.50-$8.75B guidance and evidence that Pratt MRO throughput and Raytheon conversion are improving. Until those metrics confirm, the stock offers limited upside from current levels, and any supply-chain or tariff deterioration could trigger a pullback. Accordingly, the WAIT rating stands, with a trim consideration above $235 and accumulation interest near $195.

Thesis delta

The thesis remains unchanged. The CEO's reiteration of the $289B backlog adds no new information beyond what was already disclosed in the Q2 2026 filing. The key uncertainty continues to be the conversion of backlog into revenue and free cash flow, which will determine whether the stock can grow into its valuation.